Scibase AB (SCIB) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.457x

Based on the latest financial reports, Scibase AB (SCIB) has a cash flow conversion efficiency ratio of -0.457x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-26.57 Million ≈ $-2.86 Million USD) by net assets (Skr58.11 Million ≈ $6.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Scibase AB for the company's overall valuation and market capitalisation.

Scibase AB - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Scibase AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Scibase AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Scibase AB ranked by their cash flow conversion efficiency. See Scibase AB cash debt coverage ratio to evaluate how effectively operating cash flow covers total debt obligations.

Company Cash Flow Conversion Efficiency
J and Friends Holdings Limited
NASDAQ:JF
-43.621x
Kainos Group PLC
LSE:KNOS
0.490x
N.C. Housing Public Company Limited
BK:NCH
0.024x
SUNL.TECH.G.ADR/2DL-00005
F:S790
N/A
Four Seasons Education Cayman
NYSE:FEDU
N/A
Trigon Metals Inc
V:TM
0.321x
Fiplasto SA
BA:FIPL
-0.024x
Scan Inter PCL
BK:SCN
0.030x

Annual Cash Flow Conversion Efficiency for Scibase AB (2012–2025)

The table below shows the annual cash flow conversion efficiency of Scibase AB from 2012 to 2025. View Scibase AB (SCIB) share price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Skr6.66 Million
≈ $716.29K
Skr-84.58 Million
≈ $-9.10 Million
-12.707x -711.59%
2024-12-31 Skr36.65 Million
≈ $3.94 Million
Skr-57.38 Million
≈ $-6.18 Million
-1.566x -29.68%
2023-12-31 Skr43.06 Million
≈ $4.63 Million
Skr-51.98 Million
≈ $-5.59 Million
-1.207x +31.48%
2022-12-31 Skr25.24 Million
≈ $2.72 Million
Skr-44.47 Million
≈ $-4.79 Million
-1.762x -215.78%
2021-12-31 Skr70.80 Million
≈ $7.62 Million
Skr-39.50 Million
≈ $-4.25 Million
-0.558x +22.78%
2020-12-31 Skr46.86 Million
≈ $5.04 Million
Skr-33.86 Million
≈ $-3.64 Million
-0.723x +39.05%
2019-12-31 Skr32.01 Million
≈ $3.45 Million
Skr-37.96 Million
≈ $-4.08 Million
-1.186x -126.10%
2018-12-31 Skr71.48 Million
≈ $7.69 Million
Skr-37.48 Million
≈ $-4.03 Million
-0.524x -37.36%
2017-12-31 Skr115.72 Million
≈ $12.45 Million
Skr-44.18 Million
≈ $-4.75 Million
-0.382x -47.93%
2016-12-31 Skr185.41 Million
≈ $19.95 Million
Skr-47.85 Million
≈ $-5.15 Million
-0.258x -61.43%
2015-12-31 Skr291.42 Million
≈ $31.36 Million
Skr-46.59 Million
≈ $-5.01 Million
-0.160x +85.92%
2014-12-31 Skr32.65 Million
≈ $3.51 Million
Skr-37.08 Million
≈ $-3.99 Million
-1.136x -20.76%
2013-12-31 Skr36.18 Million
≈ $3.89 Million
Skr-34.03 Million
≈ $-3.66 Million
-0.940x -161.14%
2012-12-31 Skr-23.69 Million
≈ $-2.55 Million
Skr-36.44 Million
≈ $-3.92 Million
1.538x --

About Scibase AB

ST:SCIB Sweden Medical Devices
Market Cap
$17.06 Million
Skr158.49 Million SEK
Market Cap Rank
#25695 Global
#521 in Sweden
Share Price
Skr15.50
Change (1 day)
-3.13%
52-Week Range
Skr0.21 - Skr50.80
All Time High
Skr50.80
About

SciBase Holding AB (publ), a medical technology company, develops and commercializes point-of-care platforms for skin health management in Europe, the United States, North America, Asia, Oceania, and internationally. It operates through Skin Cancer and Skin Barrier Assessment segments. The company offers Nevisense and Nevisense Go point-of-care platforms to detect melanoma and non-melanoma skin c… Read more